Food, Drugs, and Cosmetics - Gene Structure- and Function-Modifying Products - Labeling
In the Senate - Unfavorable Report by Finance; Withdrawn
Summary
The bill would prohibit the sale of any product that modifies gene structure or function unless it is labeled prominently with the phrase “gene structure‑ or function‑modifying product” and a list of all reasonably possible risks. It targets manufacturers, distributors, and retailers of such biotech products, imposing criminal and civil penalties for violations. The measure received an unfavorable report in the Senate and was subsequently withdrawn.
AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.
Topics
Track this bill
Get real-time alerts when SB 124 changes status, plus AI-powered summaries and stage predictions.
Sign up free